𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cost-effectiveness analysis of lapatinib in HER-2–positive advanced breast cancer

✍ Scribed by Quang A. Le; Joel W. Hay

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
298 KB
Volume
115
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness analysis of trastuzum
Cost-effectiveness analysis of trastuzumab in the adjuvant setting for treatment of HER2-positive breast cancer
✍ Louis P. Garrison Jr; Deborah Lubeck; Deepa Lalla; Virginia Paton; Amylou Dueck; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB 👁 2 views

## Abstract ## BACKGROUND. Adding trastuzumab to adjuvant chemotherapy provides significant clinical benefit in patients with human epidermal growth factor receptor 2 (HER2)‐positive breast cancer. A cost‐effectiveness analysis was performed to assess clinical and economic implications of adding t

Genetic counseling program in familial b
Genetic counseling program in familial breast cancer: Analysis of its effectiveness, cost and cost-effectiveness ratio
✍ Judith Balmaña; Judit Sanz; Xavier Bonfill; Alfonso Casado; Montse Rué; Ignasi G 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 95 KB 👁 1 views

## Abstract Women with a family history of breast cancer are at increased risk for developing this neoplasm. Starting surveillance more frequently at a younger age than the general population and the possibility of undergoing genetic testing are options for their medical management. We analyzed the